Search research articles
Contact Us
Filters
Showing results (11-20 of 279) with videos related to
Page
of 28
Sort By:
Journal of Neuro-Oncology
|
February 28, 2012
Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies
Fabio Efficace, Martin Taphoorn
Leukemia & Lymphoma
|
May 25, 2017
Are chronic myeloid leukemia patients ready to stop long-term treatment?
Massimo Breccia, Fabio Efficace
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 28, 2009
Implementing patient-reported health-related quality-of-life data in cancer routine practice to improve accuracy of prognosis. Are we there yet?
Catherine Legrand, Fabio Efficace
Journal of the National Cancer Institute
|
September 7, 2021
Quality of Life Improvements in Patients With Chronic Myeloid Leukemia After Stopping Long-Term Therapy: Who Can Benefit the Most?
Fabio Efficace, Michele Baccarani
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Cultural issues in assessing quality of life in cancer clinical trials
Gary S Collins, Fabio Efficace
Haematologica
|
January 2, 2013
Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications
Fabio Efficace, Francesco Lo-Coco
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 5, 2018
Sexual health in patients with hematological malignancies: a neglected issue
Pasquale Niscola, Fabio Efficace, Elisabetta Abruzzese
European Journal of Haematology
|
May 14, 2009
Asking patients with hematological malignancies: 'how do you feel?' Does it really provide independent prognostic information for survival?
Fabio Efficace, Marco Vignetti, Franco Mandelli
Leukemia Research
|
April 10, 2012
Progressive arterial occlusive disease (PAOD) and pulmonary arterial hypertension (PAH) as new adverse events of second generation TKIs in CML treatment: who's afraid of the big bad wolf?
Massimo Breccia, Fabio Efficace, Giuliana Alimena
Cancer Letters
|
November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?
Massimo Breccia, Fabio Efficace, Giuliana Alimena
Page
of 28
Search research articles
Search
Showing results (11-20 of 279) with videos related to
Sort By:
Page
of 28
Journal of Neuro-Oncology
|
February 28, 2012
Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies
Fabio Efficace, Martin Taphoorn
Leukemia & Lymphoma
|
May 25, 2017
Are chronic myeloid leukemia patients ready to stop long-term treatment?
Massimo Breccia, Fabio Efficace
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 28, 2009
Implementing patient-reported health-related quality-of-life data in cancer routine practice to improve accuracy of prognosis. Are we there yet?
Catherine Legrand, Fabio Efficace
Journal of the National Cancer Institute
|
September 7, 2021
Quality of Life Improvements in Patients With Chronic Myeloid Leukemia After Stopping Long-Term Therapy: Who Can Benefit the Most?
Fabio Efficace, Michele Baccarani
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Cultural issues in assessing quality of life in cancer clinical trials
Gary S Collins, Fabio Efficace
Haematologica
|
January 2, 2013
Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications
Fabio Efficace, Francesco Lo-Coco
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 5, 2018
Sexual health in patients with hematological malignancies: a neglected issue
Pasquale Niscola, Fabio Efficace, Elisabetta Abruzzese
European Journal of Haematology
|
May 14, 2009
Asking patients with hematological malignancies: 'how do you feel?' Does it really provide independent prognostic information for survival?
Fabio Efficace, Marco Vignetti, Franco Mandelli
Leukemia Research
|
April 10, 2012
Progressive arterial occlusive disease (PAOD) and pulmonary arterial hypertension (PAH) as new adverse events of second generation TKIs in CML treatment: who's afraid of the big bad wolf?
Massimo Breccia, Fabio Efficace, Giuliana Alimena
Cancer Letters
|
November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?
Massimo Breccia, Fabio Efficace, Giuliana Alimena
Page
of 28